{"nct_id":"NCT04853368","title":"Study to Evaluate Adverse Events and Change in Disease Activity With Oral Capsules of Galicaftor/Navocaftor/ABBV-119 or Galicaftor/Navocaftor/ABBV-576 Combination Therapies in Adult Participants With Cystic Fibrosis","status":"TERMINATED","status_verified_date":"2024-07","start_date":"2021-09-20","start_date_type":"ACTUAL","primary_completion_date":"2023-06-05","primary_completion_date_type":"ACTUAL","completion_date":"2023-06-05","completion_date_type":"ACTUAL","phases":["PHASE2"],"tickers":["ABBV"]}